Entering text into the input field will update the search result below

Blueprint Medicines Corporation's (BPMC) CEO Kate Haviland on Q2 2022 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Blueprint Medicines Corporation (NASDAQ:BPMC) Q2 2022 Earnings Conference Call August 2, 2022 8:00 AM ET

Company Participants

Jenna Cohen - Senior Director and Head of Investor Relations

Kate Haviland - Chief Executive Officer

Philina Lee - Chief Commercial Officer

Becker Hewes - MD, Chief Medical Officer

Christy Rossi - Chief Operating Officer

Mike Landsittel - Chief Financial Officer

Conference Call Participants

Ernie Rodriguez - Cowen and Company

Dane Leone - Raymond James

Andrea Tan - Goldman Sachs

Peter Lawson - Barclays

Reni Benjamin - JMP Securities

Eun Yang - Jefferies

Brad Canino - Stifel

David Nierengarten - Wedbush Securities

Paul Jeng - Guggenheim Securities

David Lebowitz - Citi

Joel Beatty - Baird

Matthew Biegler - Oppenheimer


Good morning. My name is Charlie, and I’ll be your conference operator today. At this time, I would like to welcome everyone to the Blueprint Medicine's Second Quarter 2022 Financial Results Conference Call. [Operator Instructions] After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] Thank you.

Jenna Cohen, you may begin your conference.

Jenna Cohen

Thank you, Charlie. Good morning, everyone, and welcome to Blueprint Medicines second quarter 2022 financial and operating results conference call. This morning we issued a press release, which outlines the topics we plan to discuss today. You can access the press release, as well as the slides that we'll be reviewing today by going to the Investors Section of our website at www.blueprintmedicines.com.

Joining me on today’s call are Kate Haviland, our Chief Executive Officer, who will discuss our successes in the second quarter and a look ahead to the second half of the year; Philina Lee, our Chief Commercial Officer who will provide a commercial update; Becker Hewes, Chief Medical Officer who will provide a clinical update; Christy Rossi, Chief Operating Officer, who will review our 2022 milestone progress and upcoming catalysts; and Mike

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About BPMC

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on BPMC

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.